2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseasesChern-En Chiang, Jiunn-Lee Lin, Hung‐I Yeh et al.|Journal of the Chinese Medical Association|2018Cited by 22
Difference between observed and predicted glycated hemoglobin at baseline and treatment response to vildagliptin-based dual oral therapy in patients with type 2 diabetesJun‐Sing Wang, Wayne Huey‐Herng Sheu, Yi-Jen Hung et al.|Diabetes Research and Clinical Practice|2018Cited by 9